StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
61
This year
1
Publishing Date
2024 - 03 - 07
1
2023 - 11 - 10
1
2023 - 10 - 24
1
2023 - 06 - 30
1
2023 - 06 - 27
1
2023 - 06 - 16
1
2023 - 06 - 01
1
2023 - 05 - 03
1
2023 - 02 - 15
1
2023 - 01 - 16
1
2022 - 12 - 30
1
2022 - 11 - 02
1
2022 - 10 - 06
1
2022 - 08 - 19
1
2022 - 08 - 03
1
2022 - 07 - 04
1
2022 - 06 - 27
1
2022 - 06 - 14
1
2022 - 06 - 03
1
2022 - 04 - 26
1
2022 - 04 - 21
1
2022 - 03 - 23
1
2022 - 02 - 28
1
2022 - 01 - 05
1
2021 - 11 - 09
1
2021 - 10 - 13
1
2021 - 09 - 20
1
2021 - 08 - 17
1
2021 - 08 - 05
1
2021 - 07 - 23
1
2021 - 07 - 12
1
2021 - 07 - 09
1
2021 - 07 - 07
1
2021 - 06 - 25
1
2021 - 06 - 24
1
2021 - 06 - 21
1
2021 - 06 - 17
1
2021 - 06 - 09
1
2021 - 06 - 02
1
2021 - 05 - 28
1
2021 - 05 - 24
1
2021 - 05 - 21
1
2021 - 05 - 20
1
2021 - 05 - 18
1
2021 - 05 - 12
1
2021 - 05 - 10
1
2021 - 05 - 05
1
2021 - 04 - 28
1
2021 - 04 - 23
1
2021 - 04 - 22
2
2021 - 04 - 20
1
2021 - 04 - 16
1
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 12
1
2021 - 04 - 07
1
2021 - 03 - 25
1
2021 - 03 - 19
2
2021 - 03 - 11
1
Sector
Communications
1
Health services
1
Health technology
61
Manufacturing
6
N/a
2
Process industries
2
Tags
Active
1
Alliances
1
Analgesic
1
Antiviral
1
Approval
11
Approved
1
Biosimilar
1
Breast cancer
1
Business
2
Cancer
19
Cardio
1
Cardiovascular
1
Cmo
1
Collaboration
2
Colorectal cancer
1
Commercialization
2
Companies
1
Covid
1
Disease
3
Drug
4
Duchenne
2
Expansion
1
Expected
2
Genomics
1
Global
11
Group
1
Growing
2
Growth
5
Heart
2
Hepatitis
1
Hiv
2
Hypertension
1
Immunotherapy
1
Infections
1
Life
1
Lipodystrophy
1
Market
17
Melanoma
1
Merge
1
N/a
58
News
1
People
1
Pharma
1
Profitable
1
Rare
1
Reach
1
Report
11
Research
7
Service
1
Services
1
Spac
1
Space
1
Study
1
System
2
Therapeutics
7
Therapy
3
Treat
1
Treatment
6
Virus
1
Entities
Abbott laboratories
32
Abbvie inc.
37
Adc therapeutics sa
5
Aerie pharmaceuticals, inc.
5
Agios pharmaceuticals, inc.
10
Alkermes plc
4
Alnylam pharmaceuticals, inc.
14
Amgen inc.
34
Arvinas, inc.
24
Astellas pharma inc
26
Astrazeneca plc
45
Aveo pharmaceuticals, inc.
10
Bausch health companies inc.
5
Baxter international inc.
6
Beam therapeutics inc.
6
Becton, dickinson and company
6
Beigene, ltd.
10
Biocryst pharmaceuticals, inc.
14
Biohaven pharmaceutical holding company ltd.
15
Biomarin pharmaceutical inc.
4
Biontech se
95
Blueprint medicines corporation
10
Bristol-myers squibb company
61
Clovis oncology, inc.
11
Eli lilly and company
80
Endo international plc
7
Epizyme, inc.
11
Exelixis, inc.
13
Genmab a/s
4
Gilead sciences, inc.
27
Glaxosmithkline plc
64
Global blood therapeutics, inc.
6
Ideaya biosciences, inc.
4
Illumina, inc.
12
Incyte corporation
14
Ionis pharmaceuticals, inc.
5
Johnson & johnson
76
Karyopharm therapeutics inc.
10
Moderna, inc.
7
Morgan stanley
4
Myovant sciences ltd.
14
Neurocrine biosciences, inc.
4
Novartis ag
88
Novo nordisk a/s
11
Omeros corporation
13
Opko health, inc.
6
Orange
29
Otonomy, inc.
13
Pfizer, inc.
692
Regeneron pharmaceuticals, inc.
22
Rigel pharmaceuticals, inc.
11
Sanofi
153
Seagen inc.
7
Takeda pharmaceutical company limited
23
Teva pharmaceutical industries ltd
29
Verastem, inc.
10
Viatris inc.
8
Voyager therapeutics, inc.
6
Xeris pharmaceuticals, inc.
10
Y-mabs therapeutics, inc.
10
Symbols
ABBV
88
ABT
26
ADCT
13
ADXS
8
AGIO
12
ALB
8
ALNY
11
ALPMF
11
ALPMY
11
AMGN
86
AVEO
19
AYLA
12
AZN
61
AZNCF
53
BCRX
13
BGNE
12
BHC
10
BIIB
11
BLUE
8
BMY
662
BOLT
7
BPMC
19
BSX
6
CLVS
20
EPZM
18
EXEL
29
GILD
45
GLAXF
50
GMAB
6
GNMSF
6
GSK
67
ILMN
10
INCY
24
INTS
12
JNJ
91
KPTI
19
LLY
106
MRTX
10
NKTR
7
NVO
7
NVS
103
NVSEF
82
OMER
13
OTIC
13
PFE
61
REGN
30
RIGL
11
SNY
119
SNYNF
70
TAK
43
TEVA
8
TEVJF
37
TPTX
7
TSVT
11
UCBJF
8
UCBJY
8
VSTM
11
VTRS
15
XERS
10
YMAB
18
Exchanges
Amex
1
Nasdaq
57
Nyse
61
Crawled Date
2024 - 03 - 07
1
2023 - 11 - 10
1
2023 - 10 - 24
1
2023 - 06 - 30
1
2023 - 06 - 27
1
2023 - 06 - 16
1
2023 - 06 - 01
1
2023 - 05 - 03
1
2023 - 02 - 15
1
2023 - 01 - 16
1
2022 - 12 - 30
1
2022 - 11 - 02
1
2022 - 10 - 06
1
2022 - 08 - 19
1
2022 - 08 - 03
1
2022 - 07 - 04
1
2022 - 06 - 27
1
2022 - 06 - 14
1
2022 - 06 - 03
1
2022 - 04 - 26
1
2022 - 04 - 21
1
2022 - 03 - 23
1
2022 - 02 - 28
1
2022 - 01 - 05
1
2021 - 11 - 09
1
2021 - 10 - 13
1
2021 - 09 - 20
1
2021 - 08 - 17
1
2021 - 08 - 05
1
2021 - 07 - 27
1
2021 - 07 - 12
1
2021 - 07 - 09
1
2021 - 07 - 07
1
2021 - 06 - 25
1
2021 - 06 - 24
1
2021 - 06 - 22
1
2021 - 06 - 17
1
2021 - 06 - 09
1
2021 - 06 - 02
1
2021 - 05 - 28
1
2021 - 05 - 25
1
2021 - 05 - 21
1
2021 - 05 - 20
1
2021 - 05 - 18
1
2021 - 05 - 12
1
2021 - 05 - 10
1
2021 - 05 - 05
1
2021 - 04 - 28
1
2021 - 04 - 23
1
2021 - 04 - 22
2
2021 - 04 - 20
1
2021 - 04 - 16
1
2021 - 04 - 14
1
2021 - 04 - 13
2
2021 - 04 - 07
1
2021 - 03 - 25
1
2021 - 03 - 19
2
2021 - 03 - 11
1
Crawled Time
00:00
4
01:00
1
02:00
1
06:00
1
10:51
1
11:00
5
12:00
1
12:15
1
12:34
1
13:00
3
13:07
1
13:17
1
13:20
1
13:27
1
13:50
1
14:00
2
14:03
1
14:15
1
14:20
1
15:00
5
15:15
1
15:49
1
16:00
3
17:00
2
17:37
1
17:43
1
18:00
2
18:04
1
18:26
1
18:31
2
18:32
1
18:33
1
18:40
1
18:42
1
19:00
1
19:47
1
20:00
1
20:59
1
21:00
1
22:00
1
23:00
2
Source
www.biospace.com
3
www.fda.gov
24
www.prnewswire.com
34
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Bristol-myers squibb company
symbols :
Pfe
save search
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
Published:
2024-03-07
(Crawled : 12:00)
- prnewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-6.51%
|
O:
0.04%
H:
0.44%
C:
-1.51%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-9.31%
|
O:
-2.08%
H:
0.13%
C:
-0.57%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-9.52%
|
O:
0.36%
H:
0.34%
C:
-0.54%
XFOR
|
$1.255
4.58%
4.38%
3M
|
Health Technology
|
24.55%
|
O:
0.12%
H:
0.0%
C:
-4.98%
EYPT
|
$17.665
0.94%
0.93%
1.5M
|
Health Technology
|
-15.15%
|
O:
2.56%
H:
1.37%
C:
-4.13%
AQST
|
$4.11
-8.67%
-9.49%
2.3M
|
Health Technology
|
-10.54%
|
O:
1.79%
H:
12.3%
C:
10.94%
ALKS
|
$23.86
0.42%
0.42%
2.4M
|
Health Technology
|
-17.9%
|
O:
1.11%
H:
0.96%
C:
0.65%
Oncology Drugs Market worth $520 billion by 2033 - Exclusive Report by We Market Research
Published:
2023-11-10
(Crawled : 15:00)
- prnewswire.com
AZNCF
|
$138.24
-4.19%
800
|
Health Technology
|
6.65%
|
O:
0.1%
H:
0.0%
C:
-2.14%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-20.71%
|
O:
-3.48%
H:
3.87%
C:
3.61%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-14.35%
|
O:
0.24%
H:
0.22%
C:
-0.91%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-3.38%
|
O:
-1.24%
H:
0.0%
C:
0.0%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-4.19%
|
O:
0.4%
H:
0.18%
C:
0.0%
ABBV
|
News
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
19.65%
|
O:
0.44%
H:
0.0%
C:
0.0%
AZN
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
6.51%
|
O:
-1.33%
H:
0.22%
C:
-0.11%
report
research
market
Rising R&D Investment and Government Support Fuel Expansion of Global Duchenne Muscular Dystrophy Drugs Market
Published:
2023-10-24
(Crawled : 23:00)
- prnewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-16.46%
|
O:
0.1%
H:
1.77%
C:
0.89%
LLY
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
29.23%
|
O:
2.75%
H:
0.46%
C:
-1.76%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-13.93%
|
O:
-0.18%
H:
1.34%
C:
1.05%
PTCT
|
$25.32
2.55%
2.49%
3.9M
|
Health Technology
|
8.35%
|
O:
-1.34%
H:
2.23%
C:
1.62%
LXRX
|
News
|
$1.655
1.53%
1.51%
3M
|
Health Technology
|
39.08%
|
O:
-1.68%
H:
0.85%
C:
-2.99%
expansion
global
duchenne
market
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published:
2023-06-30
(Crawled : 23:00)
- prnewswire.com
ALKS
|
$23.86
0.42%
0.42%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
NBIX
M
|
$132.03
-0.39%
-0.39%
560K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
Email alert
Add to watchlist
UCBJF
|
$126.05
-39.66%
100
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
$138.24
-4.19%
800
|
Health Technology
|
Email alert
Add to watchlist
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
report
business
life
global
therapeutics
Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published:
2023-06-27
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
11.2%
|
O:
-1.1%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-16.61%
|
O:
-0.95%
H:
0.19%
C:
-0.32%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-31.09%
|
O:
0.19%
H:
0.11%
C:
-1.46%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.46%
|
O:
-0.01%
H:
0.16%
C:
-0.32%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-11.42%
|
O:
0.03%
H:
0.12%
C:
-0.24%
GSK
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
9.18%
|
O:
-0.91%
H:
0.56%
C:
-0.5%
LLY
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
65.82%
|
O:
2.15%
H:
1.18%
C:
0.43%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-25.45%
|
O:
-0.06%
H:
0.46%
C:
0.0%
AZN
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-4.83%
|
O:
-0.21%
H:
0.42%
C:
0.13%
report
business
cancer
treat
global
Global Axial Spondyloarthritis Treatment Market to 2027: Increase in the Number of Approved Biosimilars Fuels the Sector
Published:
2023-06-16
(Crawled : 02:00)
- prnewswire.com
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
37.7%
|
O:
1.21%
H:
0.0%
C:
-0.2%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-36.05%
|
O:
0.28%
H:
1.25%
C:
0.5%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-11.47%
|
O:
0.46%
H:
0.31%
C:
-0.15%
LLY
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
65.39%
|
O:
0.41%
H:
0.26%
C:
-1.77%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-25.31%
|
O:
0.32%
H:
2.1%
C:
1.97%
approved
treatment
global
market
Peptide Therapeutics Global Market Report 2023: Increase in the Prevalence of Chronic Diseases Drives Growth
Published:
2023-06-01
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-8.59%
|
O:
-0.56%
H:
0.0%
C:
0.0%
AZNCF
|
$138.24
-4.19%
800
|
Health Technology
|
-8.39%
|
O:
-0.74%
H:
1.4%
C:
0.35%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
15.61%
|
O:
0.99%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-17.24%
|
O:
1.32%
H:
0.31%
C:
0.12%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-33.14%
|
O:
0.6%
H:
1.07%
C:
0.29%
NVO
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-21.17%
|
O:
-1.84%
H:
1.62%
C:
1.33%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-4.15%
|
O:
1.03%
H:
0.84%
C:
0.82%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-25.32%
|
O:
0.37%
H:
1.34%
C:
1.14%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-9.41%
|
O:
1.05%
H:
0.0%
C:
0.0%
AZN
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-6.28%
|
O:
0.11%
H:
0.69%
C:
-0.45%
report
global
therapeutics
growth
market
Duchenne Muscular Dystrophy Drugs Global Market Report 2023: Sector to Reach $18.1 Billion by 2030 at a 42.5% CAGR
Published:
2023-05-03
(Crawled : 18:00)
- prnewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-33.89%
|
O:
-0.73%
H:
0.68%
C:
0.16%
LLY
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
74.12%
|
O:
0.06%
H:
0.29%
C:
-0.7%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-27.52%
|
O:
-0.29%
H:
1.19%
C:
0.56%
PTCT
|
$25.32
2.55%
2.49%
3.9M
|
Health Technology
|
-54.59%
|
O:
-0.38%
H:
1.38%
C:
1.2%
LXRX
|
News
|
$1.655
1.53%
1.51%
3M
|
Health Technology
|
-39.6%
|
O:
2.19%
H:
13.21%
C:
10.0%
report
reach
global
duchenne
market
Global Melanoma Therapeutics Market to Reach $9.5 Billion by 2030
Published:
2023-02-15
(Crawled : 16:00)
- prnewswire.com
AZNCF
|
$138.24
-4.19%
800
|
Health Technology
|
-1.42%
|
O:
0.66%
H:
1.9%
C:
1.9%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-41.86%
|
O:
-0.69%
H:
0.44%
C:
-0.23%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-33.15%
|
O:
0.07%
H:
0.24%
C:
-1.15%
IOVA
M
|
$11.32
-3.41%
-3.53%
5.3M
|
Health Technology
|
60.76%
|
O:
-0.48%
H:
1.3%
C:
-0.34%
AZN
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-2.95%
|
O:
-1.28%
H:
0.56%
C:
0.36%
melanoma
global
therapeutics
market
Global Antiviral Therapeutics Market 2022 to 2027 - Rising Prevalence of Viral Diseases like HIV and Hepatitis Drives Growth
Published:
2023-01-16
(Crawled : 20:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.27%
|
O:
-0.2%
H:
0.0%
C:
0.0%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-46.88%
|
O:
-2.74%
H:
0.43%
C:
-0.99%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-16.42%
|
O:
0.33%
H:
0.33%
C:
-0.94%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-33.39%
|
O:
0.83%
H:
0.52%
C:
-1.09%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-6.26%
|
O:
-0.01%
H:
0.69%
C:
-0.1%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-7.65%
|
O:
1.1%
H:
0.22%
C:
0.02%
GILD
|
News
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-22.45%
|
O:
-0.26%
H:
0.37%
C:
-0.74%
COCP
|
$1.495
-1.39%
7.6K
|
Health Technology
|
-29.91%
|
O:
0.47%
H:
11.16%
C:
7.91%
hepatitis
global
antiviral
hiv
therapeutics
growth
market
Global Precision Cancer Therapeutics Market Report 2022: Overview of Disease Epidemiology, Leading Product sales, Market Estimates and Forecasts, and Competitive Summary of Leading Providers
Published:
2022-12-30
(Crawled : 15:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.69%
|
O:
0.77%
H:
0.0%
C:
-0.74%
AZNCF
|
$138.24
-4.19%
800
|
Health Technology
|
0.14%
|
O:
1.08%
H:
0.0%
C:
-0.25%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-50.48%
|
O:
-0.08%
H:
0.21%
C:
-0.1%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
1.62%
|
O:
-0.01%
H:
0.08%
C:
-0.95%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-18.37%
|
O:
-0.04%
H:
0.16%
C:
-0.47%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-33.01%
|
O:
0.04%
H:
0.21%
C:
-0.25%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-6.26%
|
O:
-0.39%
H:
0.0%
C:
0.0%
GILD
|
News
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-21.53%
|
O:
0.08%
H:
0.66%
C:
0.61%
EXEL
|
$22.51
0.09%
0.09%
2.3M
|
Health Technology
|
47.03%
|
O:
-0.32%
H:
2.91%
C:
2.75%
AZN
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.24%
|
O:
-0.46%
H:
0.38%
C:
0.01%
global
disease
report
therapeutics
cancer
market
Peptide Therapeutics Global Market to Reach $52.19 Billion by 2026 at a CAGR of 8.9%
Published:
2022-11-02
(Crawled : 21:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
6.42%
|
O:
-0.7%
H:
0.29%
C:
0.29%
AZNCF
|
$138.24
-4.19%
800
|
Health Technology
|
12.75%
|
O:
-2.33%
H:
3.2%
C:
3.2%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-46.0%
|
O:
-1.51%
H:
0.95%
C:
0.45%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-37.64%
|
O:
-0.26%
H:
1.87%
C:
1.59%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
5.27%
|
O:
-1.85%
H:
0.0%
C:
0.0%
AZN
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
14.35%
|
O:
-1.31%
H:
1.98%
C:
1.71%
global
therapeutics
market
Anticoagulants Market is expected to generate a revenue of USD 56.16 Billion by 2028, Globally, at 10.20% CAGR: Verified Market Research®
Published:
2022-10-06
(Crawled : 14:20)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
32.59%
|
O:
-2.53%
H:
0.0%
C:
0.0%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-42.38%
|
O:
-0.82%
H:
0.03%
C:
-1.53%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-12.24%
|
O:
-0.3%
H:
0.0%
C:
0.0%
GSK
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
30.22%
|
O:
-1.25%
H:
0.53%
C:
-0.1%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-32.4%
|
O:
-0.92%
H:
0.06%
C:
-0.78%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
14.81%
|
O:
-1.63%
H:
0.0%
C:
0.0%
research
expected
market
Red Biotechnology Market to Exceed US$ 609.6 Bn by 2031: TMR Study
Published:
2022-08-19
(Crawled : 14:00)
- prnewswire.com
AZNCF
|
$138.24
-4.19%
800
|
Health Technology
|
3.94%
|
O:
3.04%
H:
0.12%
C:
-2.22%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.26%
|
O:
-2.05%
H:
0.29%
C:
0.07%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-47.67%
|
O:
0.54%
H:
1.24%
C:
0.63%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-34.86%
|
O:
0.01%
H:
2.09%
C:
1.58%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
44.23%
|
O:
-0.62%
H:
0.57%
C:
-0.42%
GILD
|
News
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
2.64%
|
O:
-0.25%
H:
1.19%
C:
0.49%
AZN
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
2.65%
|
O:
0.78%
H:
0.49%
C:
0.22%
study
market
Global Cancer Therapies Market Report 2022: Market to Reach $209.2 Billion by 2026 - Industry Focuses on New Approaches to Treat Cancer
Published:
2022-08-03
(Crawled : 19:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-1.46%
|
O:
-1.22%
H:
1.8%
C:
1.8%
AZNCF
|
$138.24
-4.19%
800
|
Health Technology
|
3.84%
|
O:
2.52%
H:
0.0%
C:
-0.19%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
28.56%
|
O:
-2.88%
H:
0.0%
C:
-0.21%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-5.33%
|
O:
-0.29%
H:
0.72%
C:
0.58%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-49.02%
|
O:
0.08%
H:
0.29%
C:
-0.08%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
9.69%
|
O:
0.2%
H:
0.44%
C:
0.24%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-16.0%
|
O:
1.4%
H:
0.0%
C:
0.0%
GSK
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-2.99%
|
O:
0.27%
H:
0.1%
C:
-0.81%
LLY
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
139.23%
|
O:
-1.16%
H:
0.02%
C:
-1.42%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-33.83%
|
O:
-0.27%
H:
0.22%
C:
-0.92%
AZN
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
4.51%
|
O:
1.13%
H:
0.35%
C:
0.35%
global
report
cancer
market
A $41.8 Billion Global Opportunity for Small Molecule Drug Discovery by 2026 - New Research from StrategyR
Published:
2022-07-04
(Crawled : 11:00)
- prnewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
$138.24
-4.19%
800
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
News
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
drug
research
Cancer Immunotherapy Market Expands with Rising Adoption of Target Therapy in Cancer Treatment, States TMR Report
Published:
2022-06-27
(Crawled : 16:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-23.41%
|
O:
0.47%
H:
3.73%
C:
3.73%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-11.29%
|
O:
4.15%
H:
0.0%
C:
0.0%
AZNCF
|
$138.24
-4.19%
800
|
Health Technology
|
4.72%
|
O:
-1.55%
H:
4.43%
C:
0.03%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-49.9%
|
O:
1.46%
H:
1.45%
C:
0.78%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
11.43%
|
O:
1.86%
H:
1.05%
C:
0.24%
GSK
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-27.49%
|
O:
-0.16%
H:
0.61%
C:
0.18%
LLY
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
135.07%
|
O:
1.32%
H:
0.0%
C:
0.0%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-38.83%
|
O:
0.34%
H:
1.72%
C:
0.95%
SPPI
|
$1.03
-0.97%
0
|
Health Technology
|
17.05%
|
O:
0.0%
H:
2.28%
C:
-2.27%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-13.2%
|
O:
0.53%
H:
0.0%
C:
0.0%
AZN
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
2.65%
|
O:
-0.36%
H:
1.22%
C:
0.38%
immunotherapy
report
therapy
cancer
market
treatment
Global Axial Spondyloarthritis Market Research Repoirt 2022: Biopharmaceutical Companies are Trying to Match Themselves with New Technologies in the Market to Improve the Overall System
Published:
2022-06-14
(Crawled : 11:00)
- prnewswire.com
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
55.06%
|
O:
-0.22%
H:
0.0%
C:
-1.02%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-0.98%
|
O:
-0.04%
H:
0.0%
C:
0.0%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-47.87%
|
O:
-2.24%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-14.89%
|
O:
0.43%
H:
0.0%
C:
0.0%
LLY
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
158.36%
|
O:
-0.49%
H:
0.98%
C:
0.56%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-34.58%
|
O:
-0.4%
H:
0.33%
C:
-0.91%
ABBV
|
News
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
17.22%
|
O:
-1.04%
H:
0.87%
C:
-1.31%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
11.35%
|
O:
-0.41%
H:
0.73%
C:
-0.54%
research
system
companies
market
Global Panic Disorders Market Insights | Size | Shares | Trends | Growth | Industry Analysis [2020-2030] Panic disorders, also known as anxiety disorder deals with recurrent and unexpected panic attacks. PET-CT Scanner Devices Market: Competitive Landscape Analysis With Forecast by 2031 Wilmington, Delaware: According to the report, the global PET-CT scanner devices market was valued over US$ 200 Mn in 2020 and is projected to expand at a CAGR of ~3% from 2021 to 2031. Portal Hypertension Market Insights | Current Trends | Growth Opportunity | Global Industry Analysis [2020-2030] At present, treatment options for portal hypertension is limited due to the dearth of approval of specialized drugs. Spatial Genomics & Transcriptomics Market to Experience Significant Growth by 2027 Wilmington, Delaware: The spatial genomics & transcriptomics market is prognosticated to bring profitable growth during the assessment period of 2019-2027. Teleradiology Services Market to Make Great Impact in Near Future by 2031 Wilmington, Delaware: According to the report, the global teleradiology services market was valued over US$ 6.4 Bn in 2020. Anti-depressants Drugs and Therapies Market to Witness a Pronounce Growth by 2025 Wilmington, Delaware: Anti-depressants medications lower the symptoms of depression, dysthymia, chronic depression, and anxiety disorders. B-Cell Non-Hodgkin’s Lymphoma (NHL) Market to Offer Ample Growth Opportunities by 2027 Wilmington, Delaware: Non-Hodgkin’s lymphoma is a group of heterogeneous proliferative malignancies. Heightening Healthcare Spending Opening Growth Avenues for Collateral Ligament Stabilizer System Market, Reaching US$ 3.5 Billion in 2032: Fact.MR Study Fact.MR – A Market Research and Competitive Intelligence Provider: The global collateral ligament stabilizer system market is expected to reach US$ 3.5 Billion by the end of the 2022-2032 forecast period, growing at a CAGR of 6.1%, concludes a recently published report by Fact.MR. Breast Cancer Liquid Biopsy Market Trends, Growth, Analysis and Future Scope, 2026 Wilmington, Delaware: A biopsy is a tissue or cell sample taken from any part of the patient’s body and examined in the lab for the detection of cancer. Cerebral Palsy Market Size, Shares, Trends and Growth | Global Industry Analysis [2020-2030] The global cerebral palsy market is picking up steam due to increasing awareness about the condition amongst parents. Continuous Glucose Monitoring Market: Competitive Research and Precise Outlook 2021 to 2028 Wilmington, Delaware: The global continuous glucose monitoring market depicts the presence of a large competitive vendor landscape, says Transparency Market Research on the basis of a newly research report. Crow’s Feet Market Key Trends and Opportunity Analysis up to 2026 Albany NY, United States: The demand within the global crow’s feet market has been escalating on account of vital advancements in the field of dermatology in recent times. HIV Associated Lipodystrophy Syndrome Market Insights | Global Industry Analysis [2020-2030] HIV-associated lipodystrophy is a syndrome that are found in human immune-deficiency virus -infected patients who are being administered with active antiretroviral medications for the treatment of HIV infection. Global Mail Service Pharmacy Market | Size | Shares | Trends | Growth | Forecast [2020-2030]
Published:
2022-06-03
(Crawled : 06:00)
- biospace.com/
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-24.31%
|
O:
-1.55%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-13.16%
|
O:
-0.94%
H:
0.0%
C:
0.0%
AZNCF
|
$138.24
-4.19%
800
|
Health Technology
|
5.12%
|
O:
-0.4%
H:
4.05%
C:
-1.35%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-51.4%
|
O:
0.57%
H:
0.0%
C:
0.0%
GSK
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-8.4%
|
O:
-0.14%
H:
0.0%
C:
0.0%
LLY
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
142.18%
|
O:
-2.25%
H:
0.0%
C:
0.0%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-36.0%
|
O:
-1.4%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-15.17%
|
O:
-0.09%
H:
0.0%
C:
0.0%
NBIX
M
|
$132.03
-0.39%
-0.39%
560K
|
Health Technology
|
44.7%
|
O:
2.29%
H:
0.0%
C:
0.0%
AZN
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
2.67%
|
O:
-0.56%
H:
0.82%
C:
-0.64%
lipodystrophy
treatment
research
system
active
services
report
service
growing
hiv
profitable
hypertension
genomics
expected
virus
approval
cancer
growth
group
market
breast cancer
infections
Global Rheumatology Therapeutics Market Research Report to 2027 - Featuring AbbVie, Amgen and Beckman Coulter Among Others
Published:
2022-04-26
(Crawled : 13:20)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-15.47%
|
O:
-1.81%
H:
0.0%
C:
0.0%
AZNCF
|
$138.24
-4.19%
800
|
Health Technology
|
4.62%
|
O:
3.09%
H:
0.0%
C:
-2.9%
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
9.65%
|
O:
-0.33%
H:
0.0%
C:
-1.56%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-1.79%
|
O:
-1.19%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-9.75%
|
O:
-0.48%
H:
0.0%
C:
0.0%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-46.84%
|
O:
3.08%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-20.62%
|
O:
2.0%
H:
0.0%
C:
0.0%
LLY
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
163.24%
|
O:
0.34%
H:
1.41%
C:
-1.17%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-36.49%
|
O:
-0.09%
H:
1.26%
C:
-0.51%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
45.38%
|
O:
-0.22%
H:
0.43%
C:
-1.25%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-15.78%
|
O:
-0.11%
H:
0.0%
C:
0.0%
RIGL
|
$1.07
1.91%
1.87%
810K
|
Health Technology
|
-60.38%
|
O:
-0.38%
H:
4.92%
C:
-4.55%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
30.54%
|
O:
-0.72%
H:
0.0%
C:
0.0%
GILD
|
News
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
6.78%
|
O:
-0.13%
H:
0.0%
C:
0.0%
AZN
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
3.49%
|
O:
-0.03%
H:
0.53%
C:
-1.33%
research
report
therapeutics
market
← Previous
1
2
3
4
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
News
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.